Guardant Health, Inc. (GH)

USD 45.64

(4.2%)

Revenue Summary of Guardant Health, Inc.

  • Guardant Health, Inc.'s latest annual revenue in 2023 was 563.94 Million USD , up 25.45% from previous year.
  • Guardant Health, Inc.'s latest quarterly revenue in 2024 Q2 was 177.23 Million USD , up 5.19% from previous quarter.
  • Guardant Health, Inc. reported a annual revenue of 449.53 Million USD in annual revenue 2022, up 20.31% from previous year.
  • Guardant Health, Inc. reported a annual revenue of 373.65 Million USD in annual revenue 2021, up 30.32% from previous year.
  • Guardant Health, Inc. reported a quarterly revenue of 168.49 Million USD for 2024 Q1, up 8.67% from previous quarter.
  • Guardant Health, Inc. reported a quarterly revenue of 143.03 Million USD for 2023 Q3, up 4.29% from previous quarter.

Annual Revenue Chart of Guardant Health, Inc. (2023 - 2016)

Historical Annual Revenue of Guardant Health, Inc. (2023 - 2016)

Year Revenue Revenue Growth
2023 563.94 Million USD 25.45%
2022 449.53 Million USD 20.31%
2021 373.65 Million USD 30.32%
2020 286.73 Million USD 33.75%
2019 214.37 Million USD 136.52%
2018 90.63 Million USD 81.85%
2017 49.84 Million USD 97.4%
2016 25.24 Million USD 0.0%

Peer Revenue Comparison of Guardant Health, Inc.

Name Revenue Revenue Difference
Aclaris Therapeutics, Inc. 31.24 Million USD -1704.691%
Applied DNA Sciences, Inc. 13.36 Million USD -4118.817%
Aspira Women's Health Inc. 9.15 Million USD -6060.673%
Biodesix, Inc. 49.08 Million USD -1048.874%
BioNexus Gene Lab Corp. 9.77 Million USD -5671.765%
bioAffinity Technologies, Inc. 2.53 Million USD -22168.439%
bioAffinity Technologies, Inc. 2.53 Million USD -22168.439%
Bionano Genomics, Inc. 36.11 Million USD -1461.491%
CareDx, Inc 280.32 Million USD -101.177%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 219.78 Million USD -156.587%
DarioHealth Corp. 20.35 Million USD -2670.971%
Exact Sciences Corporation 2.49 Billion USD 77.44%
Fulgent Genetics, Inc. 289.21 Million USD -94.994%
ICON Public Limited Company 8.12 Billion USD 93.055%
IDEXX Laboratories, Inc. 3.66 Billion USD 84.596%
Illumina, Inc. 4.5 Billion USD 87.479%
Intelligent Bio Solutions Inc. 3.11 Million USD -18022.998%
iSpecimen Inc. 9.92 Million USD -5580.273%
Standard BioTools Inc. 106.34 Million USD -430.325%
MDxHealth SA 70.19 Million USD -703.425%
23andMe Holding Co. 219.63 Million USD -156.762%
Medpace Holdings, Inc. 1.88 Billion USD 70.096%
Myriad Genetics, Inc. 678.4 Million USD 16.871%
Mainz Biomed B.V. 895.47 Thousand USD -62877.245%
ENDRA Life Sciences Inc. - USD -Infinity%
NeoGenomics, Inc. 591.64 Million USD 4.681%
Neogen Corporation 924.22 Million USD 38.981%
Inotiv, Inc. 572.42 Million USD 1.481%
Natera, Inc. 1.08 Billion USD 47.907%
OpGen, Inc. 3.41 Million USD -16397.812%
OPKO Health, Inc. 863.49 Million USD 34.69%
Psychemedics Corporation 22.09 Million USD -2452.032%
Prenetics Global Limited 21.74 Million USD -2493.738%
Prenetics Global Limited 21.74 Million USD -2493.738%
Precipio, Inc. 15.19 Million USD -3610.917%
Personalis, Inc. 73.48 Million USD -667.475%
RadNet, Inc. 1.61 Billion USD 65.116%
Sera Prognostics, Inc. 306 Thousand USD -184196.732%
Sotera Health Company 1.04 Billion USD 46.254%
Neuronetics, Inc. 71.34 Million USD -690.419%
Star Equity Holdings, Inc. 45.78 Million USD -1131.731%
Star Equity Holdings, Inc. 45.78 Million USD -1131.731%
Trinity Biotech plc 56.83 Million USD -892.307%
T2 Biosystems, Inc. 7.19 Million USD -7740.234%
Twist Bioscience Corporation 312.97 Million USD -80.19%
Exagen Inc. 52.54 Million USD -973.205%